<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hanko EKR</submitter><funding>Engineering and Physical Sciences Research Council</funding><pagination>312</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11575205</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Flavonoids are a structurally diverse group of secondary metabolites, predominantly produced by plants, which include a range of compounds with pharmacological importance. Pinocembrin is a key branch point intermediate in the biosynthesis of a wide range of flavonoid subclasses. However, replicating the biosynthesis of these structurally diverse molecules in heterologous microbial cell factories has encountered challenges, in particular the modest pinocembrin titres achieved to date. In this study, we combined genome engineering and enzyme candidate screening to significantly enhance the production of pinocembrin and its derivatives, including chrysin, pinostrobin, pinobanksin, and galangin, in Escherichia coli.&lt;h4>Results&lt;/h4>By implementing a combination of established</pubmed_abstract><journal>Microbial cell factories</journal><pubmed_title>Engineering an Escherichia coli strain for enhanced production of flavonoids derived from pinocembrin.</pubmed_title><pmcid>PMC11575205</pmcid><funding_grant_id>EP/S01778X/1</funding_grant_id><pubmed_authors>Scrutton NS</pubmed_authors><pubmed_authors>Hanko EKR</pubmed_authors><pubmed_authors>Bhanot S</pubmed_authors><pubmed_authors>Jervis AJ</pubmed_authors><pubmed_authors>Robinson CJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Engineering an Escherichia coli strain for enhanced production of flavonoids derived from pinocembrin.</name><description>&lt;h4>Background&lt;/h4>Flavonoids are a structurally diverse group of secondary metabolites, predominantly produced by plants, which include a range of compounds with pharmacological importance. Pinocembrin is a key branch point intermediate in the biosynthesis of a wide range of flavonoid subclasses. However, replicating the biosynthesis of these structurally diverse molecules in heterologous microbial cell factories has encountered challenges, in particular the modest pinocembrin titres achieved to date. In this study, we combined genome engineering and enzyme candidate screening to significantly enhance the production of pinocembrin and its derivatives, including chrysin, pinostrobin, pinobanksin, and galangin, in Escherichia coli.&lt;h4>Results&lt;/h4>By implementing a combination of established</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-04T20:39:02.258Z</modification><creation>2025-04-04T20:39:02.258Z</creation></dates><accession>S-EPMC11575205</accession><cross_references><pubmed>39558341</pubmed><doi>10.1186/s12934-024-02582-z</doi></cross_references></HashMap>